Insulin glargine in enteric tube feeding

Diabetes Research and Clinical Practice

Volumn 78, Issue 2, 2007, Pages 298-299

  Marchetti, Gloria ^a   Tesauro, Manfredi ^a   Di Daniele, Nicola ^a   Bollea, Maria Rosa ^a   Lauro, Renato ^a   Bertoli, Aldo ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN GLARGINE;

AGED; ALZHEIMER DISEASE; BRAIN ISCHEMIA; CASE REPORT; COGNITIVE DEFECT; DEHYDRATION; ENTERIC FEEDING; FEMALE; HUMAN; HYPERGLYCEMIA; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS;

AGED; ALZHEIMER DISEASE; DIABETES MELLITUS, TYPE 2; ENTERAL NUTRITION; FEMALE; HUMANS; INSULIN;

EID: 34548837985     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2007.03.011     Document Type: Letter

References (4)

1. Rosenstock J., Daily G., Massi-Benedetti M., Fritsche A., Lin Z., and Salzman A. Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes. Diabetes Care 28 (2005) 950-955
2. Schreiber S.A., and Haak T. Insulin glargine benefits with type 2 diabetes inadequately controlled on oral antidiabetic treatment: an observational study of everyday practice in 12,216 patients. Diabetes Obes. Metab. 9 (2007) 31-38
3. Putz D., and Kabadi U.M. Insulin glargine in continuous enteric tube feeding. Diabetes Care 25 (2002) 1889-1890
4. Fatati G., Mirri E., Del Tosto S., Palazzi M., Vendetti A.M., Mattei R., et al. Use of insulin glargine in patients with hyperglycaemia receiving artificial nutrition. Acta Diabetol. 42 (2005) 182-186